Mechanistic description
Pharmacological enhancement of nuclear import receptors (importins/karyopherins) could counter deleterious cytoplasmic TDP-43 phase transitions by maintaining nuclear localization. This would prevent the cytoplasmic mislocalization that precedes pathological aggregation.
Debate provenance: derived from debate sess_sda-2026-04-01-gap-006 on question: TDP-43 undergoes liquid-liquid phase separation that becomes pathological. Small molecules targeting phase separation properties could be therapeutic but the design principles are undefined.. Consensus signal: clinical_trialist, domain_expert, medicinal_chemist, skeptic, synthesizer, theorist discussed the mechanism terms Enhancers, Import, Nuclear, Receptor, TARDBP, TDP, aggregation. Novelty signal: skeptic-discussed-with-qualified-concession.
Evidence for (1)
Evidence matrix
Cite this hypothesis
Cite this hypothesis
etl-backfill (2026). Nuclear Import Receptor Enhancers. SciDEX hypothesis. https://prism.scidex.ai/hypotheses/h-debate-ac3b63c9a8ec
@misc{scidex_hypothesis_hdebatea,
title = {Nuclear Import Receptor Enhancers},
author = {etl-backfill},
year = {2026},
howpublished = {SciDEX hypothesis},
url = {https://prism.scidex.ai/hypotheses/h-debate-ac3b63c9a8ec},
note = {SciDEX artifact hypothesis:h-debate-ac3b63c9a8ec}
}